Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02912845 |
|
Recruitment Status :
Completed
First Posted : September 23, 2016
Last Update Posted : September 5, 2021
|
Sponsor:
Kamada, Ltd.
Collaborator:
Kedrion S.p.A.
Information provided by (Responsible Party):
Kamada, Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 13, 2019 |
| Actual Study Completion Date : | November 13, 2019 |